Skip to main content
. 2018 Dec 5;17(2):1559–1564. doi: 10.3892/ol.2018.9797

Figure 5.

Figure 5.

Relationship between p53 protein expression and survival in patients with lung cancer. The median survival time of patients with p53-positive expression was 16.8 months, and the 3-year survival rate was 31.5%. The median survival time of p53-negative patients was 19.8 months, and the 3-year survival rate was 49.6%. There was a statistically significant difference between the two groups (P<0.05).